Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Phibro Animal Health (PAHC) over the last 13 years, with Q4 2025 value amounting to $1.4 billion.

  • Phibro Animal Health's Liabilities and Shareholders Equity rose 933.82% to $1.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $5.5 billion, marking a year-over-year increase of 2981.76%. This contributed to the annual value of $1.4 billion for FY2025, which is 3855.86% up from last year.
  • As of Q4 2025, Phibro Animal Health's Liabilities and Shareholders Equity stood at $1.4 billion, which was up 933.82% from $1.4 billion recorded in Q3 2025.
  • Phibro Animal Health's 5-year Liabilities and Shareholders Equity high stood at $1.4 billion for Q4 2025, and its period low was $805.0 million during Q1 2021.
  • Its 5-year average for Liabilities and Shareholders Equity is $1.0 billion, with a median of $965.9 million in 2023.
  • As far as peak fluctuations go, Phibro Animal Health's Liabilities and Shareholders Equity grew by 18.31% in 2024, and later skyrocketed by 4338.61% in 2025.
  • Over the past 5 years, Phibro Animal Health's Liabilities and Shareholders Equity (Quarter) stood at $849.0 million in 2021, then increased by 13.3% to $961.8 million in 2022, then grew by 1.13% to $972.7 million in 2023, then soared by 32.16% to $1.3 billion in 2024, then grew by 9.34% to $1.4 billion in 2025.
  • Its Liabilities and Shareholders Equity was $1.4 billion in Q4 2025, compared to $1.4 billion in Q3 2025 and $1.4 billion in Q2 2025.